Table 2. Women’s Characteristics Enrolled during Intervention Period.

			Intervention Group	Control Group
			n (%)	n (%)
Characteristics of women enrolled during intervention period	N° of women		405	482
	Agea,b		26.9 (5.9)	27.3 (6.3)
	Parityc,d		2 (1–3)	2 (1–3)
	Gestational agea,e		37.7 (2.6)	37.4 (2.9)
	Diagnosisf	Complications of Abortionk	73/405 (18.0%)	177/478 (37.0%)
		Postpartum Uterine Atonyj	163/405 (40.3%)	146/478 (30.5%)
		Retained Placentai	97/405 (24.0%)	85/478 (17.8%)
		Lacerations/Genital Traumaj	51/405 (12.6%)	34/478 (7.1%)
		Placental Abruptioni	7/405 (1.7%)	19/478 (4.0%)
		Placenta Previa	3/405 (0.7%)	5/478 (1.1%)
		Ectopic Pregnancy	3/405 (0.7%)	5/478 (1.1%)
		Ruptured Uterus	2/405 (0.5%)	5/478 (1.1%)
		Placenta Accretai	5/405 (1.2%)	0/478 (0.0%)
		Molar Pregnancy	1/405 (0.3%)	2/478 (0.4%)
	Estimated REVEALED blood loss at study entry (mL)c,g		500 (480–700)	500 (500–800)
	MAP<60 at study entryh		129/399 (32.3%)	149/475 (31.4%)
	Unconscious at study entry		11/403 (2.7%)	13/477 (2.7%)

Note: Wilcoxon Rank Sum test utilized to test all continuous variables due to non-normality. Chi-square test used for categorical values except where noted.

^aMean (Standard Deviation).

^bN° of women in the Intervention Group: 404; N° of women in the Control Group: 476.

^cMedian (Interquartile Range) is reported.

^dN° of women in the Intervention Group: 404; N° of women in the Control Group: 472.

^eFor those ≥24 weeks; does not include cases with molar or ectopic pregnancies or abortion. N° of women in the Intervention Group: 291; N° of women in the Control Group: 250.

^fFisher’s exact test used for categorical values.

^gN° of women in the Intervention Group: 391; N° of women in the Control Group: 447.

^hMAP was measured as ([(2 * diastolic BP)+systolic BP]/3); includes women with non-palpable BP.

ⁱSignificant difference between intervention groups where p<0.05.

^jSignificant difference between intervention groups where p<0.01.

^kSignificant difference between intervention groups where p<0.001.